A detailed history of Montag A & Associates Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Montag A & Associates Inc holds 783 shares of REGN stock, worth $549,548. This represents 0.04% of its overall portfolio holdings.

Number of Shares
783
Previous 785 0.25%
Holding current value
$549,548
Previous $825,000 0.24%
% of portfolio
0.04%
Previous 0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$1024.09 - $1201.76 $2,048 - $2,403
-2 Reduced 0.25%
783 $823,000
Q2 2024

Jul 31, 2024

SELL
$883.2 - $1071.19 $143,078 - $173,532
-162 Reduced 17.11%
785 $825,000
Q1 2024

May 07, 2024

BUY
$902.69 - $993.35 $18,053 - $19,867
20 Added 2.16%
947 $911,000
Q4 2023

Feb 07, 2024

BUY
$775.18 - $881.7 $599,989 - $682,435
774 Added 505.88%
927 $814,000
Q2 2023

Aug 09, 2023

SELL
$700.03 - $830.35 $1,400 - $1,660
-2 Reduced 1.29%
153 $109,000
Q4 2022

Feb 02, 2023

BUY
$705.89 - $766.39 $17,647 - $19,159
25 Added 19.23%
155 $111,000
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $62,179 - $79,037
130 New
130 $63,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.